Abstract:BACKGROUND & OBJECTIVE:Human papillomavirus type 16 (HPV16) is the predominant high-risk type of HPV in cervical cancer tissues. Serum antibody responded to HPV16-related proteins is associated with the development of cervical cancer. This study was to construct and purify recombinant HPV16 E6 protein, detect its corresponding serum antibody among different populations, and explore the correlation of HPV16 E6 serum antibody reaction to cervical cancer.METHODS:HPV16 E6 early gene was constructed into pRSET-A expression vector. The plasmids were transfected into BL21 (DE3) cells, which were induced to express HPV16 E6 protein by isopropylthio-beta-D-galactoside (IPTG). E6 inclusions were denatured, purified through Ni column, and renatured. After the activity of HPV16 E6 protein being identified, the antibodies against HPV16 E6 in serum samples from 80 healthy women, 46 chronic cervicitis patients, and 32 cervical cancer patients were determined by ELISA using the fusion protein as antigen. HPV DNA genotype was estimated in cervical cancer tissues by fluorescence polarization.RESULTS:HPV16 E6 fusion protein of Mr 24x10(3) was expressed in pRSET-16E6 after induction of IPTG. The fusion protein was accounted for 22.3% of total bacterial proteins, and expressed as inclusive body. After purification with Ni-NTA agarose resin, the purity of the recombinant protein was over 95%, and its activity was identified by ELISA. The antibody-positive rate was significantly higher in cervical cancer patients than in healthy women and chronic cervicitis patients (31.2% vs. 5.0% and 6.5%, P<0.01). In the 32 cervical cancer patients, the positive rates of HPVs DNA and HPV16 DNA in cancer tissues were 90.61% and 46.88%. The antibody-positive rate of HPV16 E6 was higher in HPV16 DNA-positive cervical cancer patients than in HPV16 DNA-negative patients (46.7% vs. 17.6%), but the difference was not significant.CONCLUSIONS:HPV16 E6 fusion protein obtained from pRSET-A/BL21 can be used in serologic studies on cervical cancer-related HPV infection. Serum antibody against HPV16 E6 is more common in cervical cancer patients than in healthy women and chronic cervicitis patients.

Cloning, Expression, and Purification of the rE2 Protein Human Papillomavirus type 16

Construction, Expression, Purification and Identification of Chimeric HPV16 E7-L1 Virus Like Particles

[Cloning and Expressing of Human Papillomavirus 16 E7C Subgene].

Cloning and Expression of HPV 6b E7 Gene

[Cloning of Human Papillomavirus Type 16 E7 Gene and Expression in E. Coli].

Cloning and Prokaryotic Expressing of Human Papillomavirus Type 16 E5 Transforming Gene

Digital RNA Sequencing of Human Epidermal Keratinocytes Carrying Human Papillomavirus Type 16 E7

Expression and Purification of HPV58 E1 Protein and Preparation of Polyclonal Antibodies against HPV 58 E1 Protein

[Expression, Purification, and Serum Antibody Detection of HPV16 E6 in Cervical Cancer Patients].

Cloning and Expression of E6 Gene of Human Papillomavirus Type 58

Prokaryotic Expression and Polyclonal Antibody Preparation of HPV6b E7 Protein

Expression and Purification of the HPV16E7-HSP70 Fusion Protein in Escherichia coli

Preparation of a Monoclonal Antibody Against the Human Papillomavirus Type 16 E7 (HPV 16 E7 ) Protein

[Expression and Polyclonal Antibody Preparation of HPV-11E7 Protein].

Construction of Recombinant HPV16 E7 Antigen Vaccinia Virus

A RESEARCH FOR THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS AND HUMAN UTERINE CERVICAL-CARCINOMA .2. MOLECULAR GENETIC AND ULTRASTRUCTURAL-STUDY ON THE TRANSFORMING ACTIVITY OF RECOMBINANT RETROVIRUS CONTAINING HUMAN PAPILLOMAVIRUS TYPE-16 SUBGENOMIC SEQUENCES

Stable High-Level Expression of Truncated Human Papillomavirus Type 16 L1 Protein in Drosophila Schneider-2 Cells.

Highly Efficient and Economical Baculovirus Expression System for Preparing Human Papillomavirus Type16 Virus-like Particle

Expression and Purification of HPV58 E1^E4 Fusion Protein and Preparation of Polyclonal Antibody Against HPV58 E1^E4

[Expression Purification and Clinical Application of High-Risk HPV16 E4 Gene].

Construction of the Expression Plasmid Paav-Ires-hrgfp Encoding the Human Papillomavirus 16 E6E7